Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market
The global Gastrointestinal OTC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Gastrointestinal OTC Drugs Scope and Segment
The global Gastrointestinal OTC Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Gastrointestinal OTC Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Gastrointestinal OTC Drugs key manufacturers in this market include:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market
The global Gastrointestinal OTC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Gastrointestinal OTC Drugs Scope and Segment
The global Gastrointestinal OTC Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Gastrointestinal OTC Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Gastrointestinal OTC Drugs key manufacturers in this market include:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
1 Gastrointestinal OTC Drugs Market Overview
1.1 Gastrointestinal OTC Drugs Product Overview
1.2 Gastrointestinal OTC Drugs Market Segment by Type
1.2.1 Laxatives
1.2.2 Anti-Flatulents
1.2.3 H2-Antaginists
1.2.4 Anti-Diarrheals
1.2.5 PPIs
1.2.6 Anti-Emetics
1.2.7 Other
1.3 Global Gastrointestinal OTC Drugs Market Size by Type
1.3.1 Global Gastrointestinal OTC Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
2 Global Gastrointestinal OTC Drugs Market Competition by Company
2.1 Global Top Players by Gastrointestinal OTC Drugs Sales (2016-2021)
2.2 Global Top Players by Gastrointestinal OTC Drugs Revenue (2016-2021)
2.3 Global Top Players Gastrointestinal OTC Drugs Price (2016-2021)
2.4 Global Top Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal OTC Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Gastrointestinal OTC Drugs Market
2.8 Key Manufacturers Gastrointestinal OTC Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal OTC Drugs Status and Outlook by Region
3.1 Global Gastrointestinal OTC Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Gastrointestinal OTC Drugs Historic Market Size by Region
3.2.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Region
3.3.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Gastrointestinal OTC Drugs by Application
4.1 Gastrointestinal OTC Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Gastrointestinal OTC Drugs Market Size by Application
4.2.1 Global Gastrointestinal OTC Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
5 North America Gastrointestinal OTC Drugs by Country
5.1 North America Gastrointestinal OTC Drugs Historic Market Size by Country
5.1.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
5.2 North America Gastrointestinal OTC Drugs Forecasted Market Size by Country
5.2.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
6 Europe Gastrointestinal OTC Drugs by Country
6.1 Europe Gastrointestinal OTC Drugs Historic Market Size by Country
6.1.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
6.2 Europe Gastrointestinal OTC Drugs Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Gastrointestinal OTC Drugs by Region
7.1 Asia-Pacific Gastrointestinal OTC Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Gastrointestinal OTC Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2022-2027)
8 Latin America Gastrointestinal OTC Drugs by Country
8.1 Latin America Gastrointestinal OTC Drugs Historic Market Size by Country
8.1.1 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Gastrointestinal OTC Drugs Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Gastrointestinal OTC Drugs by Country
9.1 Middle East and Africa Gastrointestinal OTC Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Gastrointestinal OTC Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Gastrointestinal OTC Drugs Business
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Corporation Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Corporation Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 Procter & Gamble
10.5.1 Procter & Gamble Corporation Information
10.5.2 Procter & Gamble Introduction and Business Overview
10.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
10.5.5 Procter & Gamble Recent Development
10.6 Perrigo
10.6.1 Perrigo Corporation Information
10.6.2 Perrigo Introduction and Business Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
10.6.5 Perrigo Recent Development
10.7 Abbott
10.7.1 Abbott Corporation Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
10.7.5 Abbott Recent Development
10.8 Sanofi
10.8.1 Sanofi Corporation Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
10.8.5 Sanofi Recent Development
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Corporation Information
10.9.2 Teva Pharmaceutical Introduction and Business Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
10.9.5 Teva Pharmaceutical Recent Development
10.10 Nestle
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
10.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Nestle Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Corporation Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Corporation Information
10.12.2 Reckitt Benckiser Introduction and Business Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Products Offered
10.12.5 Reckitt Benckiser Recent Development
10.13 Purdue Pharma
10.13.1 Purdue Pharma Corporation Information
10.13.2 Purdue Pharma Introduction and Business Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Purdue Pharma Gastrointestinal OTC Drugs Products Offered
10.13.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal OTC Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal OTC Drugs Industrial Chain Analysis
11.4 Gastrointestinal OTC Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal OTC Drugs Distributors
12.3 Gastrointestinal OTC Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Gastrointestinal OTC Drugs Product Overview
1.2 Gastrointestinal OTC Drugs Market Segment by Type
1.2.1 Laxatives
1.2.2 Anti-Flatulents
1.2.3 H2-Antaginists
1.2.4 Anti-Diarrheals
1.2.5 PPIs
1.2.6 Anti-Emetics
1.2.7 Other
1.3 Global Gastrointestinal OTC Drugs Market Size by Type
1.3.1 Global Gastrointestinal OTC Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
2 Global Gastrointestinal OTC Drugs Market Competition by Company
2.1 Global Top Players by Gastrointestinal OTC Drugs Sales (2016-2021)
2.2 Global Top Players by Gastrointestinal OTC Drugs Revenue (2016-2021)
2.3 Global Top Players Gastrointestinal OTC Drugs Price (2016-2021)
2.4 Global Top Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal OTC Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Gastrointestinal OTC Drugs Market
2.8 Key Manufacturers Gastrointestinal OTC Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal OTC Drugs Status and Outlook by Region
3.1 Global Gastrointestinal OTC Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Gastrointestinal OTC Drugs Historic Market Size by Region
3.2.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Region
3.3.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Gastrointestinal OTC Drugs by Application
4.1 Gastrointestinal OTC Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Gastrointestinal OTC Drugs Market Size by Application
4.2.1 Global Gastrointestinal OTC Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Gastrointestinal OTC Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Gastrointestinal OTC Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Gastrointestinal OTC Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
5 North America Gastrointestinal OTC Drugs by Country
5.1 North America Gastrointestinal OTC Drugs Historic Market Size by Country
5.1.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
5.2 North America Gastrointestinal OTC Drugs Forecasted Market Size by Country
5.2.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
6 Europe Gastrointestinal OTC Drugs by Country
6.1 Europe Gastrointestinal OTC Drugs Historic Market Size by Country
6.1.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
6.2 Europe Gastrointestinal OTC Drugs Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Gastrointestinal OTC Drugs by Region
7.1 Asia-Pacific Gastrointestinal OTC Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Gastrointestinal OTC Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2022-2027)
8 Latin America Gastrointestinal OTC Drugs by Country
8.1 Latin America Gastrointestinal OTC Drugs Historic Market Size by Country
8.1.1 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Gastrointestinal OTC Drugs Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Gastrointestinal OTC Drugs by Country
9.1 Middle East and Africa Gastrointestinal OTC Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Gastrointestinal OTC Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Gastrointestinal OTC Drugs Business
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Corporation Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Pfizer
10.2.1 Pfizer Corporation Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Corporation Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 Procter & Gamble
10.5.1 Procter & Gamble Corporation Information
10.5.2 Procter & Gamble Introduction and Business Overview
10.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
10.5.5 Procter & Gamble Recent Development
10.6 Perrigo
10.6.1 Perrigo Corporation Information
10.6.2 Perrigo Introduction and Business Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
10.6.5 Perrigo Recent Development
10.7 Abbott
10.7.1 Abbott Corporation Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
10.7.5 Abbott Recent Development
10.8 Sanofi
10.8.1 Sanofi Corporation Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
10.8.5 Sanofi Recent Development
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Corporation Information
10.9.2 Teva Pharmaceutical Introduction and Business Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
10.9.5 Teva Pharmaceutical Recent Development
10.10 Nestle
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
10.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Nestle Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Corporation Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Corporation Information
10.12.2 Reckitt Benckiser Introduction and Business Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Products Offered
10.12.5 Reckitt Benckiser Recent Development
10.13 Purdue Pharma
10.13.1 Purdue Pharma Corporation Information
10.13.2 Purdue Pharma Introduction and Business Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Purdue Pharma Gastrointestinal OTC Drugs Products Offered
10.13.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal OTC Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal OTC Drugs Industrial Chain Analysis
11.4 Gastrointestinal OTC Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal OTC Drugs Distributors
12.3 Gastrointestinal OTC Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
